Medication info

Bistidine Tablet

Prescription medicationTabletOralExpired
Ingredient · strength
Ranitidine Hydrochloride›84mg / 1 tabletSucralfate Hydrate›300mg / 1 tabletTripotassium Bismuth Dicitrate›100mg / 1 tablet
Manufacturer / importer
Youngpoong Pharmaceutical Co., Ltd.
Appearance
Green round film-coated tablet
Packaging
30 tablets/bottle, 500 tablets/bottle
Approval status
Expired

MFDS item code 201904773 · Approved 2019.07.16

This product's status changed to Expired on 2024.07.16. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of gastrointestinal disorders (ulcers, gastritis, etc.) and Zollinger-Ellison syndrome, and prevention of Mendelson syndrome
Who takes it
Adults
Adult dose
○ Adults Usually, take 2 tablets orally twice daily, in the morning and at bedtime, regardless of meals. 1) Gastric and duodenal ulcers Take 2 tablets twice daily or 4 tablets once daily at bedtime. A higher healing rate may be achieved, particularly in patients with duodenal ulcers, by administering 4 tablets twice daily, in the morning and at bedtime. The same dosage applies to the treatment of ulcers caused by nonsteroidal anti-inflammatory drugs (NSAIDs) and to concomitant treatment to prevent gastric or duodenal ulcers during long-term NSAID use. Conditions caused by NSAID use usually heal within 4 weeks, while ulcers generally heal within 8 weeks; however, healing may take longer in some patients. For patients with recurrent ulcers who responded well to short-term treatment with this medicine, administer 2 tablets once daily at bedtime as maintenance therapy. 2) Reflux esophagitis Take 2 tablets twice daily for 8 weeks or 4 tablets once daily at bedtime. For patients with severe reflux esophagitis, the dose may be increased to 4 tablets four times daily. 3) Zollinger-Ellison syndrome Initiate treatment with 2 tablets three times daily and increase the dose as needed. For severe disease, up to 6 g of ranitidine daily may be administered as directed by a physician. 4) Upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, and acute gastric mucosal lesions When oral administration becomes possible, switch from injection to oral administration and take 2 tablets twice daily. 5) Pre-anesthetic medication (prevention of Mendelson syndrome) Take 2 tablets 2 hours before induction of anesthesia. It is also preferable to take 2 tablets on the night before surgery.

Ingredients

Manufacturer
Youngpoong Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of gastrointestinal disorders (ulcers, gastritis, etc.) and Zollinger-Ellison syndrome, and prevention of Mendelson syndrome

  • Gastric and duodenal ulcers
  • gastritis
  • Zollinger-Ellison syndrome
  • gastroesophageal reflux disease
  • Mendelson's syndrome
  • post-operative ulcers
  • ulcers due to non-steroidal anti-inflammatory drugs.
View approved original text

This medication is used for gastrointestinal-related disorders including gastric and duodenal ulcers, gastritis, Zollinger-Ellison syndrome, and gastroesophageal reflux disease. It is also effective in treating post-operative ulcers and ulcers caused by non-steroidal anti-inflammatory drugs (NSAIDs). Before anesthesia, it may be administered to prevent Mendelson's syndrome. This medication helps alleviate symptoms by regulating gastric acid secretion and aids in treatment. It protects the gastric mucosa and reduces inflammation, improving healthy gastrointestinal function. Therefore, it is used in the treatment of various gastrointestinal disorders.

How to take

Adult dose

○ Adults Usually, take 2 tablets orally twice daily, in the morning and at bedtime, regardless of meals. 1) Gastric and duodenal ulcers Take 2 tablets twice daily or 4 tablets once daily at bedtime. A higher healing rate may be achieved, particularly in patients with duodenal ulcers, by administering 4 tablets twice daily, in the morning and at bedtime. The same dosage applies to the treatment of ulcers caused by nonsteroidal anti-inflammatory drugs (NSAIDs) and to concomitant treatment to prevent gastric or duodenal ulcers during long-term NSAID use. Conditions caused by NSAID use usually heal within 4 weeks, while ulcers generally heal within 8 weeks; however, healing may take longer in some patients. For patients with recurrent ulcers who responded well to short-term treatment with this medicine, administer 2 tablets once daily at bedtime as maintenance therapy. 2) Reflux esophagitis Take 2 tablets twice daily for 8 weeks or 4 tablets once daily at bedtime. For patients with severe reflux esophagitis, the dose may be increased to 4 tablets four times daily. 3) Zollinger-Ellison syndrome Initiate treatment with 2 tablets three times daily and increase the dose as needed. For severe disease, up to 6 g of ranitidine daily may be administered as directed by a physician. 4) Upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, and acute gastric mucosal lesions When oral administration becomes possible, switch from injection to oral administration and take 2 tablets twice daily. 5) Pre-anesthetic medication (prevention of Mendelson syndrome) Take 2 tablets 2 hours before induction of anesthesia. It is also preferable to take 2 tablets on the night before surgery.

Precautions

This medication is not safe for patients on dialysis or those with kidney function issues. Additionally, individuals who have previously shown allergic reactions to this drug or its components should not take it. Patients with a history of acute porphyria should also avoid this medication, particularly women who are pregnant or may become pregnant, as well as premature infants and newborns. Patients who need to restrict potassium intake should also refrain from using this medication. Patients with compromised liver function, those with drug allergy histories, the elderly, and those with renal dysfunction histories should use this drug cautiously, especially if taken alongside NSAIDs. This medication may mask the symptoms of gastric cancer, so patients with gastric ulcers or those over middle age who have developed new symptoms of dyspepsia should ensure that it is not a malignant condition before using it. Patients with positive Helicobacter pylori in gastric or duodenal ulcers should receive treatment to eradicate the bacteria. Severe patients or those with dysphagia should also exercise caution with this medication. Rarely, allergic reactions, skin rashes, blood abnormalities, liver function abnormalities, gastrointestinal symptoms, and neurological symptoms may occur while taking this drug, so if any unusual symptoms arise, immediate consultation with healthcare professionals is necessary. Long-term use is not recommended, and it is important to use the minimal effective dose while closely monitoring treatment progress. If dizziness or drowsiness occurs, avoid driving or operating hazardous machinery. This medication may interact with other drugs, so it is essential to inform healthcare providers of any other medications being taken. It is safest for pregnant or breastfeeding women to avoid this medication. Due to insufficient safety and efficacy data, it is preferable to avoid using this medication in children. In the case of overdose, appropriate treatment such as inducing vomiting or gastric lavage is necessary, and dialysis may be required if needed. This medication reduces gastric acid secretion, which can promote bacterial growth in the stomach; therefore, regular ophthalmic examinations are recommended with long-term use.

Side effects

  • Anaphylactic shock
  • skin rash
  • urticaria
  • angioedema
  • fever
  • bronchospasm
  • hypotension
  • chest pain
  • granulocytopenia
  • leukopenia
Show 56 more
  • thrombocytopenia
  • elevated serum creatinine
  • elevated serum aminotransferases
  • agranulocytosis
  • pancytopenia
  • myelotoxicosis
  • aplastic anemia
  • acquired immune hemolytic anemia
  • eosinophilia
  • elevated AST
  • elevated ALT
  • elevated r-GTP
  • elevated ALP
  • icteric hepatitis
  • non-icteric hepatitis
  • tachycardia
  • bradycardia
  • atrioventricular block
  • premature ventricular contractions
  • arrhythmia
  • vasculitis
  • nausea
  • vomiting
  • constipation
  • diarrhea
  • abdominal distension
  • abdominal pain
  • loss of appetite
  • dizziness
  • drowsiness
  • confusion
  • convulsions
  • agitation
  • insomnia
  • headache
  • heaviness of the head
  • malaise
  • anxiety
  • mental confusion
  • depression
  • hallucinations
  • blurred vision
  • involuntary movement disorder
  • consciousness disturbance
  • hepatic myoclonus
  • gynecomastia
  • excessive milk secretion
  • erectile dysfunction
  • decreased libido
  • arthralgia
  • myalgia
  • rhabdomyolysis
  • alopecia
  • glossitis
  • pruritus
  • acute interstitial nephritis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container, away from air and moisture, at a temperature between 1 degree to 30 degrees Celsius. Proper storage will help maintain the drug's efficacy and prevent deterioration.

Appearance and packaging

Appearance

Green round film-coated tablet

Package unit

30 tablets/bottle, 500 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.